Ephrata Cancer Center is a clinical research site located in Ephrata, Pennsylvania, United States 17522.
Crixeo Clinical Trials Trust Score: 32/100 (FAILING). This profile has not yet been claimed by the site owner.
Ephrata Cancer Center has participated in 125 clinical trials with 83 currently active.
Therapeutic areas: Rectal Adenocarcinoma, Stage II Rectal Cancer AJCC v7, Stage III Rectal Cancer AJCC v7.
Sponsors: National Cancer Institute (NCI), National Heart, Lung, and Blood Institute (NHLBI), Alliance for Clinical Trials in Oncology.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Pennsylvania · View every site in Ephrata
Trust Score: 32/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Ephrata Cancer Center has a Crixeo Trust Score of 32/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Ephrata Cancer Center has 125 clinical trials on record, with 83 currently active. Their work covers Rectal Adenocarcinoma, Stage II Rectal Cancer AJCC v7, Stage III Rectal Cancer AJCC v7.
Ephrata Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.